FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charis Matsouka

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Meletios A Dimopoulos; M Gkotzamanidou; Charis Matsouka; D Mparmparoussi; N Nikitas; Erasmia Psimenou; Maria Roussou; Maria Spyropoulou-Vlachou; Evangelos Terpos; Efstathios Kastritis
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
John V Terrovitis; Argirios Ntalianis; Stefania Sventzouri; Despina Barbarousi; Elisabeth Kaldara; Chris Kapelios; Charis Matsouka; John N Nanas
Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.
Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Despina Mparmparousi; Nikitas Nikitas; Evangelos Terpos; Maria Roussou Magdalini Migkou Maria Gavriatopoulou; Dimitra Gika; Meletios A Dimopoulos
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charis Matsouka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Meletios A Dimopoulos; M Gkotzamanidou; Charis Matsouka; D Mparmparoussi; N Nikitas; Erasmia Psimenou; Maria Roussou; Maria Spyropoulou-Vlachou; Evangelos Terpos; Efstathios Kastritis
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
Leukemia 2013;27(2):423-9.
2012: John V Terrovitis; Argirios Ntalianis; Stefania Sventzouri; Despina Barbarousi; Elisabeth Kaldara; Chris Kapelios; Charis Matsouka; John N Nanas
Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.
Journal of the American College of Cardiology 2012;60(21):2255-6.
2011: Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Despina Mparmparousi; Nikitas Nikitas; Evangelos Terpos; Maria Roussou Magdalini Migkou Maria Gavriatopoulou; Dimitra Gika; Meletios A Dimopoulos
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2011;11(5):409-13.
2011: Magdalini Migkou; Despina Mparmparoussi; Nikitas Nikitas; Maria Roussou; Evangelos Terpos; Maria Gavriatopoulou; Dimitra Gika; Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Meletios A Dimopoulos
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy.
European journal of haematology 2011;87(4):323-9.
2010: Meletios A Dimopoulos; Efstathios Kastritis; D Christoulas; M Migkou; M Gavriatopoulou; M Gkotzamanidou; M Iakovaki; Charis Matsouka; D Mparmparoussi; Maria Roussou; Eleni Efstathiou; Evangelos Terpos
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.
Leukemia 2010;24(10):1769-78.
2010: Meletios A Dimopoulos; Dimitrios Christoulas; Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Charis Matsouka; Despoina Mparmparoussi; Erasmia Psimenou; Irini Grapsa; Eleni Efstathiou; Evangelos Terpos
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
European journal of haematology 2010;85(1):1-5.
2010: Paraskevi Savvari; Charis Matsouka; Despoina Barbaroussi; Dimitrios Christoulas; Nikitas Nikitas; Meletios A Dimopoulos; Christos A Papadimitriou
Burkitt's lymphoma in pregnancy with bilateral breast involvement: case report with review of the literature.
Onkologie 2010;33(8-9):461-4.
2009: Maria Roussou; Anna Tasidou; Meletios A Dimopoulos; Efstathios Kastritis; M Migkou; D Christoulas; M Gavriatopoulou; F Zagouri; Charis Matsouka; D Anagnostou; Evangelos Terpos
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Leukemia 2009;23(11):2177-81.
2009: Meletios A Dimopoulos; Maria Roussou; Maria Gavriatopoulou; Flora Zagouri; Magdalini Migkou; Charis Matsouka; Despina Barbarousi; Dimitrios Christoulas; Erasmia Primenou; Irini Grapsa; Evangelos Terpos; Efstathios Kastritis
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Clinical lymphoma & myeloma 2009;9(4):302-6.
2008: Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Erasmia Psimenou; Irini Grapsa; Charis Matsouka; Despina Barmparousi; Evangelos Terpos; Meletios Athanasios Dimopoulos
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Leukemia & lymphoma 2008;49(5):890-5.
2008: Spyros Michopoulos; Kalliopi Petraki; Charis Matsouka; Efstathios Kastritis; Heleni Chrysanthopoulou; Meletios Athanasios Dimopoulos
Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1555-7.
2008: Charis Matsouka; Spyridon Marinopoulos; Despina Barbaroussi; Aris Antsaklis
Acute lymphoblastic leukemia during gestation.
Medical oncology (Northwood, London, England) 2008;25(2):190-3.
2007: Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou; Dimitra Gika; Charis Matsouka; Despina Barmparousi; Irini Grapsa; Erasmia Psimenou; Aristotelis Bamias; Meletios A Dimopoulos
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.
Haematologica 2007;92(4):546-9.
2007: Maria Roussou; Athanasios Anagnostopoulos; Efstathios Kastritis; Charis Matsouka; Despina Barmparousi; Vassiliki Koutsoukou; Meletios A Dimopoulos
Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: long term follow up and disease control after subsequent treatments.
Leukemia & lymphoma 2007;48(4):754-8.
2006: John N Nanas; Charis Matsouka; Drosos Karageorgopoulos; Anastasia Leonti; Elias Tsolakis; Stavros G Drakos; Eleftheria P Tsagalou; George D Maroulidis; George P Alexopoulos; John Kanakakis; Maria I Anastasiou-Nana
Etiology of anemia in patients with advanced heart failure.
Journal of the American College of Cardiology 2006;48(12):2485-9.
2004: John V Terrovitis; Charis Matsouka; Athanasios Anagnostopoulos; Maria I Anastasiou-Nana; Athanassios Meletios Dimopoulos
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma.
Clinical lymphoma 2004;5(3):194-6.
2004: Kalliopi Karatzi; Christos M Papamichael; Konstantinos Aznaouridis; Emmanouil N Karatzis; John Lekakis; Charis Matsouka; George Boskou; Antonia Chiou; Marietta Sitara; Giorgia Feliou; Dimitrios P Kontoyiannis; Antonis Zampelas; Myron Mavrikakis
Constituents of red wine other than alcohol improve endothelial function in patients with coronary artery disease.
Coronary artery disease 2004;15(8):485-90.
2004: Meletios A Dimopoulos; Dimitra Gika; Konstantinos Zervas; Marie-Christine Kyrtsonis; Argyris Symeonidis; Athanasios Anagnostopoulos; Konstantinos L Bourantas; Charis Matsouka; Gerassimos A Pangalis
The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.
Leukemia & lymphoma 2004;45(9):1809-13.
2003: Meletios A Dimopoulos; George Hamilos; Eleni Efstathiou; Ioannis Siapkaras; Charis Matsouka; Dimitra Gika; Vassiliki Grigoraki; Christos Papadimitriou; Dimitrios Mitsibounas; Nikolaos Anagnostopoulos
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Leukemia & lymphoma 2003;44(6):993-6.
2003: Meletios A Dimopoulos; Costas Tsatalas; Athanasios Zomas; George Hamilos; Panayiotis Panayiotidis; Dimitris Margaritis; Charis Matsouka; Theofanis Economopoulos; Nikolaos Anagnostopoulos
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
Seminars in oncology 2003;30(2):265-9.
2001: Meletios A Dimopoulos; Athanasios Zomas; Nora Viniou; Vassiliki Grigoraki; Eleni Galani; Charis Matsouka; O Economou; Nikolaos Anagnostopoulos; Panayiotis Panayiotidis
Treatment of Waldenstrom's macroglobulinemia with thalidomide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3596-601.
1999: Meletios A Dimopoulos; Eleni Galani; Charis Matsouka
Waldenström's macroglobulinemia.
Hematology/oncology clinics of North America 1999;13(6):1351-66.